Health care utilization and economic burden of dermatologic adverse drug reactions (ADRs) in patients with NSCLC treated with an epidermal growth factor receptor inhibitor (EGFRI).
Vijayveer Bonthapally
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
Annie Guerin
Employment or Leadership Position - Analysis Group
Eric Q. Wu
Employment or Leadership Position - Analysis Group
Genevieve Gauthier
Employment or Leadership Position - Analysis Group
Martin Cloutier
Employment or Leadership Position - Analysis Group
Kyle D. Holen
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
Saurabh Ray
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories